SCHEMBL24076801

SCHEMBL24076801

Clc1ccc2[nH]c(-c3nnc(CN4CCN(Cc5ccccc5)CC4)[nH]3)cc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 5/20 0.49
▸ DRD4 P21917 4/20 0.48
▸ DRD2 P14416 1/20 0.48
▸ DRD3 P35462 1/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ KDM4E B2RXH2 1/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ NPC1 O15118 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ LMNA P02545 1/20 0.48
▸ MAPT P10636 1/20 0.48
▸ CYP19A1 P11511 1/20 0.48
▸ RAB9A P51151 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ CHEK1 O14757 3/20 0.46
▸ CDK7 P50613 1/20 0.44
▸ MCHR1 Q99705 1/20 0.43
▸ HTR3E A5X5Y0 1/20 0.42
▸ HTR3B O95264 1/20 0.42
▸ HTR1A P08908 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30381307 0.89 ALDH1A1 (0.55) KMT2AKDM4EMEN1NPC1ALDH1A1
SCHEMBL24077247 0.89 ALDH1A1 (0.55) KMT2AKDM4EMEN1NPC1ALDH1A1
SCHEMBL24077245 0.88 IDO1 (0.48) SIGMAR1DRD4DRD2DRD3KMT2A
SCHEMBL24077267 0.88 DRD4 (0.46) SIGMAR1DRD4DRD2DRD3KMT2A
SCHEMBL25787876 0.77 ALDH1A1 (0.54) DRD4KDM4EALDH1A1MAPTCHEK1
SCHEMBL30301437 0.77 ALDH1A1 (0.54) DRD4KDM4EALDH1A1MAPTCHEK1
SCHEMBL24077244 0.77 ALDH1A1 (0.53) KMT2AKDM4EMEN1NPC1ALDH1A1
SCHEMBL24076629 0.77 GRIN1 (0.53) KDM4EALDH1A1MAPT
SCHEMBL24077271 0.76 GRIN1 (0.66) —
SCHEMBL24077277 0.76 GRIN1 (0.53) SMN1; SMN2CHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116057053-A 5-membered heteroaryl derivatives containing at least one N and pharmaceutical compositions containing the same as active ingredient for preventing or treating mental disorders 大邱庆北尖端医疗产业振兴财团 2023-05-02 — — CN claimed
CN-116057053-B 5-Membered heteroaryl derivatives containing at least one N and pharmaceutical compositions containing the same as active ingredient for preventing or treating mental disorders 特立尼奥公司 2024-12-31 — — CN disclosed
US-20230212144-A1 5-MEMBERED HETEROARYL DERIVATIVE CONTAINING AT LEAST ONE N, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MENTAL DISORDERS, CONTAINING SAME AS ACTIVE INGREDIENT TRINEURO (KR) 2023-07-06 — — US disclosed
CN-116057053-A 5-membered heteroaryl derivatives containing at least one N and pharmaceutical compositions containing the same as active ingredient for preventing or treating mental disorders 大邱庆北尖端医疗产业振兴财团 2023-05-02 — — CN disclosed
WO-2021241982-A1 5-MEMBERED HETEROARYL DERIVATIVE CONTAINING AT LEAST ONE N, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MENTAL DISORDERS, CONTAINING SAME AS ACTIVE INGREDIENT 재단법인 대구경북첨단의료산업진흥재단 2021-12-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230212144-A1 5-MEMBERED HETEROARYL DERIVATIVE CONTAINING AT LEAST ONE N, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MENTAL DISORDERS, CONTAINING SAME AS ACTIVE INGREDIENT HTR5A, HTR2C, TPH1 SIGMAR1 716/4885DRD4 17/4885DRD2 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback